United States · Venture startup

Who invested in Touchlight Genetics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 31 Oct 2026

Undisclosedraised across 1 round since 2014, from 1 source

Latest round
VentureOct 2014
Investors
1
See who backed them

The rounds

  1. Oct 2014
    VentureAmount undisclosed

    From a historical funding record

Founders and team

From Touchlight Genetics's own website: 1 founder, 10 on the team.

Jonny OhlsonExecutive Chair & Founder
  • Karen FallenChief Executive Officer
  • Bradley TheobaldGeneral Counsel & Chief of Staff
  • Dr Jill MakinChief Scientific Officer
  • Dr Tommy DuncanChief Business Officer
  • David EdwardsNon-Executive Director
  • David LewisNon-Executive Director
  • Ingo EschweilerNon-Executive Director
  • Leopoldo ZambelettiNon-Executive Director
  • Thomas HardingNon-Executive Director
  • Will DownieNon-Executive Director

Everyone who backed them

Downing VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Touchlight Genetics

Who invested in Touchlight Genetics?

Touchlight Genetics's investors include Downing Ventures.

How much has Touchlight Genetics raised?

Touchlight Genetics has raised 1 round since 2014, none with a disclosed amount.

When did Touchlight Genetics last raise?

Touchlight Genetics's most recent round was a Venture in Oct 2014.

Who backed Touchlight Genetics first?

Touchlight Genetics's first round on record, in Oct 2014, was backed by Downing Ventures.

What stage is Touchlight Genetics at?

Touchlight Genetics's latest named round is a Venture, in Oct 2014.

Where is Touchlight Genetics based?

Touchlight Genetics is based in the United States.

Companies like Touchlight Genetics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.